novo nordisk semaglutide patent Ozempic's problem: how lost control of a blockbuster drug. 💉 Demand for Novo Nordisk opens new front

Available at: Yusri K et al

Ozempic (active ingredient: semaglutide) is a widely prescribed medication for managing type 2 diabetes, known for its ability to improve blood sugar control (or, in other words, to lower blood sugar levels) and promote weight loss

Gently massage it onto damp skin in circular motions, focusing on rough areas like elbows, knees, or dry patches

Adults with a BMI of 30 or higher generally qualify for semaglutide therapy, while individuals with a BMI between 27 and 29.9 who also have weight-related health conditions such as high blood pressure, type 2 diabetes, or cardiovascular disease may also be candidates

In the study, participants were given the antifungal drug nystatin for 10 days, but only half of them also followed a Candida -focused diet for 3 months